Michael McCaul sold NBIX on August 26, 2024 | PolitAlpha
Michael McCaul sold NBIX (Neurocrine Biosciences Inc) on Aug 26, 2024 with an estimated value between $1,000 and $15,000. This trade was filed under spouse. The stock is currently down 13.5% from the trade price.